echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Beijing Fuyuan "Omeshatan ester hydrochlorochlorine tablets" was approved for listing the second domestic.

    Beijing Fuyuan "Omeshatan ester hydrochlorochlorine tablets" was approved for listing the second domestic.

    • Last Update: 2020-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The umosatan hydrochlorophenidate tablet is a fixed-dose compound preparation developed by DAIICHISANKYO, which is mainly used to treat hypertension.
    the drug was first marketed in the U.S. in 2003 and approved for import in 2010.
    the drug as a Medicare Class B drug, the latest winning bid in China is 6.46 yuan per tablet.
    2019, sales of Omishatan ester hydrochlorochlorophenicol tablets in domestic grade hospitals will be approximately RMB83.21 million.
    Insight database shows that at present, in addition to the original research, only Huahai Pharmaceuticals in August the first imitation was approved, Beijing Fuyuan was approved as the second, no other enterprises have submitted a listing application.
    only one company in the BE phase, for Zhejiang Nord Pharmaceuticals.
    five other companies have been clinically approved, but most of them will not be clinical except for Luoxin, Shandong Province, in 2005/2006.
    , the drug is still vacant in the market, approved generics companies are expected to occupy a larger market share.
    from: Insight Database ()
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.